[The clinico-immunological variants of drug-induced toxic hepatitis in pulmonary tuberculosis patients].
Clinical and immunological variants were assessed in 62 patients with toxic drug hepatitis due to tuberculostatic therapy. Three clinicoimmunological variants of toxic hepatitis were recognized. They need to be accounted for when deciding on immunocorrection.
Frolov
V M
VM
Peresadin
N A
NA
Petrunia
A M
AM
D000995:Antitubercular Agents / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000276:immunology*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006510:Hepatitis B Antibodies / Q000097:blood; D006511:Hepatitis B Antigens / Q000097:blood; D006801:Humans; D007111:Immunity, Cellular; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy / Q000276:immunology
D000995:Antitubercular Agents; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens
Kliniko-immunologicheskie varianty medikamentoznykh toksicheskikh gepatitov u bol'nykh tuberkulezom legkikh.